Torray Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Sell |
54,012
-10,635
| -16% | -$3.79M | 2.79% | 15 |
|
|
2025
Q4 | $21.2M | Sell |
64,647
-7,883
| -11% | -$2.5M | 3.03% | 11 |
|
|
2025
Q3 | $20.5M | Buy |
72,530
+2,672
| +4% | +$775K | 2.78% | 10 |
|
|
2025
Q2 | $19.5M | Buy |
69,858
+12,539
| +22% | +$3.55M | 2.83% | 8 |
|
|
2025
Q1 | $17.9M | Sell |
57,319
-2,808
| -5% | -$829K | 2.66% | 9 |
|
|
2024
Q4 | $15.7M | Buy |
60,127
+47,969
| +395% | +$14.2M | 2.25% | 14 |
|
|
2024
Q3 | $3.92M | Sell |
12,158
-3,099
| -20% | -$1.01M | 0.55% | 55 |
|
|
2024
Q2 | $4.77M | Buy |
15,257
+104
| +0.7% | +$30.6K | 0.71% | 48 |
|
|
2024
Q1 | $4.31M | Buy |
15,153
+1,322
| +10% | +$387K | 0.65% | 49 |
|
|
2023
Q4 | $3.98M | Sell |
13,831
-549
| -4% | -$150K | 0.64% | 49 |
|
|
2023
Q3 | $3.86M | Buy |
14,380
+531
| +4% | +$133K | 0.68% | 49 |
|
|
2023
Q2 | $3.07M | Buy |
13,849
+3,360
| +32% | +$780K | 0.53% | 52 |
|
|
2023
Q1 | $2.54M | Buy |
10,489
+761
| +8% | +$187K | 0.45% | 60 |
|
|
2022
Q4 | $2.55M | Sell |
9,728
-853
| -8% | -$229K | 0.46% | 62 |
|
|
2022
Q3 | $2.38M | Sell |
10,581
-2,622
| -20% | -$636K | 0.48% | 55 |
|
|
2022
Q2 | $3.21M | Sell |
13,203
-1,779
| -12% | -$436K | 0.61% | 52 |
|
|
2022
Q1 | $3.62M | Buy |
14,982
+834
| +6% | +$192K | 0.58% | 54 |
|
|
2021
Q4 | $3.18M | Buy |
14,148
+3,816
| +37% | +$805K | 0.47% | 54 |
|
|
2021
Q3 | $2.2M | Buy |
10,332
+1,272
| +14% | +$293K | 0.34% | 60 |
|
|
2021
Q2 | $2.21M | Buy |
9,060
+644
| +8% | +$158K | 0.32% | 61 |
|
|
2021
Q1 | $2.09M | Buy |
8,416
+356
| +4% | +$84.9K | 0.33% | 59 |
|
|
2020
Q4 | $1.85M | Buy |
8,060
+1,026
| +15% | +$237K | 0.31% | 68 |
|
|
2020
Q3 | $1.79M | Buy |
7,034
+49
| +0.7% | +$12.1K | 0.33% | 61 |
|
|
2020
Q2 | $1.65M | Sell |
6,985
-1,497
| -18% | -$342K | 0.31% | 68 |
|
|
2020
Q1 | $1.72M | Sell |
8,482
-3,282
| -28% | -$717K | 0.38% | 56 |
|
|
2019
Q4 | $2.84M | Sell |
11,764
-281
| -2% | -$61.9K | 0.49% | 53 |
|
|
2019
Q3 | $2.33M | Buy |
12,045
+43
| +0.4% | +$8.25K | 0.25% | 56 |
|
|
2019
Q2 | $2.21M | Buy |
12,002
+1,596
| +15% | +$286K | 0.23% | 61 |
|
|
2019
Q1 | $1.98M | Buy |
10,406
+501
| +5% | +$95.7K | 0.21% | 63 |
|
|
2018
Q4 | $1.93M | Sell |
9,905
-1,736
| -15% | -$339K | 0.23% | 59 |
|
|
2018
Q3 | $2.41M | Buy |
11,641
+892
| +8% | +$176K | 0.24% | 56 |
|
|
2018
Q2 | $1.98M | Buy |
10,749
+1,579
| +17% | +$279K | 0.21% | 59 |
|
|
2018
Q1 | $1.56M | Buy |
9,170
+854
| +10% | +$157K | 0.16% | 65 |
|
|
2017
Q4 | $1.45M | Buy |
8,316
+2,673
| +47% | +$473K | 0.14% | 69 |
|
|
2017
Q3 | $1.05M | Buy |
+5,643
| New | +$1,000K | 0.1% | 73 |
|
Other funds holding AMGN
VCM
VPM
Torray Investment Partners's AMGN Position: Q1 2026 in Review
Torray Investment Partners reduced its Amgen (AMGN) stake by 16% in Q1 2026, selling an estimated $3.79M and leaving 54,012 shares worth $19M. The position accounts for 2.79% of the portfolio, ranked #15.
Torray Investment Partners first reported a position in AMGN in Q3 2017 and has held it in 35 quarters since. The position peaked at $21.2M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Torray Investment Partners held 54,012 shares of Amgen worth $19M as of Q1 2026.
- Torray Investment Partners sold 10,635 Amgen shares in Q1 2026, an estimated $3.79M.
- Amgen made up 2.79% of Torray Investment Partners's portfolio in Q1 2026, its #15 holding.
- Torray Investment Partners first reported a position in Amgen in Q3 2017 and has held it in 35 quarters since.
- Torray Investment Partners's Amgen position peaked at $21.2M in Q4 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.